SCHEMBL19959239

SCHEMBL19959239

COCCOC[C@H]1CCCNC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 3/20 0.43
CHRNA4 P43681 3/20 0.43
EED O75530 1/20 0.39
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
SCN9A Q15858 1/20 0.35
HRH3 Q9Y5N1 3/20 0.34
HRH4 Q9H3N8 2/20 0.34
CPN1 P15169 1/20 0.34
CPB2 Q96IY4 1/20 0.34
MAP2K1 Q02750 1/20 0.34
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
KMT2A Q03164 1/20 0.32
KDM1A O60341 1/20 0.32
FEN1 P39748 1/20 0.32
NAAA Q02083 1/20 0.31
EPHX1 P07099 1/20 0.31
SYK P43405 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5230643 1.00 CHRNB2 (0.43) CHRNB2CHRNA4EEDCHRNB4CHRNA3
SCHEMBL19959245 1.00 CHRNB2 (0.43) CHRNB2CHRNA4EEDCHRNB4CHRNA3
SCHEMBL5233144 0.91 CHRNB2 (0.43) CHRNB2CHRNA4EEDCHRNB4CHRNA3
SCHEMBL5236601 0.86 CHRNB2 (0.43) CHRNB2CHRNA4EEDCHRNB4CHRNA3
Tert-Butyl Formate SCHEMBL27675695 0.85 CHRNB2 (0.38) CHRNB2CHRNA4EEDCHRNB4CHRNA3
SCHEMBL18183307 0.84 CHRNB2 (0.44) CHRNB2CHRNA4EEDCHRNB4CHRNA3
SCHEMBL1484881 0.83
SCHEMBL1088927 0.83
SCHEMBL792732 0.83
SCHEMBL19959091 0.82 CHRNB2 (0.43) CHRNB2CHRNA4EEDCHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919856-B2 Cyclohexene compounds and use thereof GUANGZHOU HENOVCOM BIOSCIENCE CO. LTD. (CN) 2021-02-16 US disclosed
US-20190241520-A1 CYCLOHEXENE COMPOUNDS AND USE THEREOF GUANGZHOU HENOVCOM BIOSCIENCE CO. LTD. (CN) 2019-08-08 US disclosed
WO-2018045950-A1 CYCLOHEXENE COMPOUNDS AND USE THEREOF 广州市恒诺康医药科技有限公司 2018-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190241520-A1 CYCLOHEXENE COMPOUNDS AND USE THEREOF CYP51A1, FURIN, CYP21A2 CHRNB2 3271/4885CHRNA4 3599/4885EED 4032/4885
US-10919856-B2 Cyclohexene compounds and use thereof CYP51A1, FURIN, CYP21A2 CHRNB2 3271/4885CHRNA4 3599/4885EED 4032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.